Local
Masimo Wins FDA Clearance for Brain Monitoring Tech
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Orange County Business Journal

Irvine-based Masimo, now a subsidiary of Danaher, received FDA 510(k) clearance for its next-generation smartSedLine brain monitoring technology to help clinicians better assess patients’ responses to anesthesia. “Every patient responds differently to anesthesia, and understanding those individual responses is critical to optimizing depth of sedation and informing care,” Dr. Basil Matta, chief medical officer of Masimo, said in a statement. Masimo added improvements to the technology, including a Patient State Index algorithm that provides faster readings of brain activity during anesthesia induction and more stable measurements when electroencephalography (EEG) signals are weak. The clearance marks Masimo’s seventh FDA clearance in 2026.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Orange County Business Journal



